news
Takeda to acquire ARIAD Pharmaceuticals
The transaction has been approved unanimously by the boards of directors of both companies, and is expected to close by the end of February 2017.
List view / Grid view
Takeda Pharmaceutical Company Ltd
news
TB Alliance and Takeda advance programme to find new TB treatments
22 June 2016 | By Victoria White, Digital Content Producer
TB Alliance and Takeda are to explore hits generated from a high-throughput screening programme conducted to find novel compounds to treat tuberculosis...
news
Tri-I TDI expands focus to include antibody drug discovery
17 June 2016 | By Victoria White, Digital Content Producer
Tri-I TDI will extend its current relationship with Takeda from the realm of small molecule discovery into the new research area of antibody drug discovery...
news
Takeda and Frazier Healthcare Partners launch Outpost Medicine
15 March 2016 | By Victoria White
Outpost Medicine is a biopharmaceutical company focused on the development of new treatments of urologic and gynaecologic diseases and disorders...
news
Mersana and Takeda expand partnership to advance XMT-1522
3 February 2016 | By Victoria White
XMT-1522 is an investigational, Fleximer-based ADC therapy that targets HER2-expressing tumours, including breast, gastric and non-small cell lung cancers...
news
ADC Summit 2016 to highlight the developments for next wave of antibody-drug conjugates
29 January 2016 | By SMi Group
Registration now live for the 5th annual ADC Summit taking place at the Holiday Inn Kensington Forum, London, UK on the 23rd – 24th May 2016...
news
Takeda and NsGene to research encapsulated cell therapies in Parkinson’s disease
8 January 2016 | By Victoria White
The partnership will focus on the delivery of recombinant Glial Cell Line-Derived Neurotrophic Factor to affected brain regions by way of implanted, encapsulated cell therapy devices...
news
Takeda and Enterome enter microbiome drug discovery collaboration
6 January 2016 | By Victoria White
As part of the collaboration, Enterome will use its metagenomic platform to support the discovery of potential novel agents derived from gut bacteria and directed to gastrointestinal targets...
news
Kyoto University and Takeda T-CiRA Programme begins
15 December 2015 | By Victoria White
The "Takeda-CiRA Joint Programme for iPS Cell Applications" (T-CiRA) will begin research in six core directions to explore clinical applications of stem cells in therapeutic areas including cancer, heart failure and diabetes mellitus...
news
Takeda and Cour in coeliac disease collaboration
10 December 2015 | By Victoria White
The partnership will focus on using nanotechnologies based on Cour’s Tolerizing Immune Modifying nanoParticle (TIMP) platform...
news
UCL and Takeda to identify targets for neurodegenerative diseases
14 October 2015 | By Victoria White
The three-year collaboration will focus on mechanistic approaches for the identification of genes or signalling pathways that modify neurodegenerative disease processes affecting neuronal health...
news
Takeda joins malaria and TB drug discovery consortium, WIPO Re:Search
14 September 2015 | By Victoria White
WIPO Re:Search provides access to the intellectual property of certain pharmaceutical compounds, technologies, know-how and data for R&D activities around TB and malaria...
news
Gencia and Takeda to develop novel mitochondrial therapeutics
11 September 2015 | By Victoria White
Gencia and Takeda aim to jointly research and develop two preclinical drug candidates, one each in the areas of inflammation and oncology...